Literature DB >> 11926861

Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis.

Jan A M van Laar1, Corinne M P Buysse, Ann C T M Vossen, Björn Hjálmarsson, Bart van Den Berg, Kirsten van Lom, Jaap Deinum.   

Abstract

We describe 2 immunocompetent adolescents with fulminant infectious mononucleosis and virus-associated hemophagocytosis. A new quantitative polymerase chain reaction revealed high serum Epstein-Barr virus DNA levels in these patients. One patient died with an increasing viral load not responding to corticosteroids followed by antiviral and intensified immunomodulatory treatment. The other patient received corticosteroids and acyclovir at diagnosis; her rapid recovery was heralded by a steep decline of viral load. We propose monitoring the clinical course of fulminant infectious mononucleosis in immunocompetent patients by Epstein-Barr virus DNA quantification and prompt corticosteroid and antiviral therapy when viral load is high.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926861     DOI: 10.1001/archinte.162.7.837

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.

Authors:  Samira Fafi-Kremer; Patrice Morand; Come Barranger; Gérard Barguès; Stéphane Magro; Jérôme Bés; Philippe Bourgeois; Martine Joannes; Jean-Marie Seigneurin
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 2.  Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome?

Authors:  I Steiner; G Rosenberg; I Wirguin
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman's disease complicated by hemophagocytic lymphohistiocytosis.

Authors:  Timo C E Zondag; Casper Rokx; Kirsten van Lom; Arjan R van den Berg; Pieter Sonneveld; Willem A Dik; Gerard J J van Doornum; King H Lam; Jan A M van Laar
Journal:  Int J Hematol       Date:  2015-12-21       Impact factor: 2.490

4.  Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.

Authors:  Kazuhiko Hayashi; Zaishun Jin; Sachiyo Onoda; Hiromasa Joko; Norihiro Teramoto; Nobuya Ohara; Wakako Oda; Takehiro Tanaka; Yi-Xuan Liu; Tirtha Raj Koirala; Takashi Oka; Eisaku Kondo; Tadashi Yoshino; Kiyoshi Takahashi; Tadaatsu Akagi
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.

Authors:  Hal B. Jenson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

6.  Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.

Authors:  Y N'guyen; L Andreoletti; M Patey; C Lecoq-Lafon; P Cornillet; A Léon; R Jaussaud; C Fieschi; C Strady
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

7.  Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye.

Authors:  Meav-Lang J Lay; Robyn M Lucas; Mala Ratnamohan; Janette Taylor; Anne-Louise Ponsonby; Dominic E Dwyer
Journal:  Virol J       Date:  2010-09-22       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.